For example, shERα cells have been observed to markedly diminish the expression of angiogenic molecular markers, including vascular endothelial growth factor A (VEGF-A) and angiopoietin-2 (Ang-2), in breast cancer cells. The gene discussed is VEGFA; the disease is breast carcinoma.